nejm semaglutide ckd Incidence of Chronic Kidney Disease among Adults with Diabetes, 2015–2020 FLOW Study Highlights: How Semaglutide

284 Machann, J

Novo Nordisk has launched the Medicare GLP-1 Bridge, making Wegovy available to eligible Medicare beneficiaries for $50 a month through the end of 2027, giving millions of older adults with obesity a structured pathway to the FDA-approved weight management drug

Side effects, contraindications, and what to discuss with your provider before starting

Who Should Use Caution and When to Contact Your Provider Patients with a personal history of pancreatitis, medullary thyroid cancer, multiple endocrine neoplasia type 2, or severe dehydration should avoid GLP-1 therapy or use it only under close specialist supervision